Published guidance, NICE advice and quality standards | Guidance

Showing 261 to 270 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma	TA766	2 February 2022	2 February 2022
Ponesimod for treating relapsing–remitting multiple sclerosis	TA767	2 February 2022	2 February 2022
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs	TA768	2 February 2022	2 February 2022
Palforzia for treating peanut allergy in children and young people	TA769	2 February 2022	2 February 2022
Sodium zirconium cyclosilicate for treating hyperkalaemia	TA599	4 September 2019	24 January 2022
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection	TA761	19 January 2022	19 January 2022
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer	TA760	12 January 2022	12 January 2022
Cabotegravir with rilpivirine for treating HIV-1	TA757	5 January 2022	5 January 2022
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy	TA758	5 January 2022	5 January 2022
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis	TA756	16 December 2021	16 December 2021